Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens

por Morrisette, Taylor, Alosaimy, Sara, Lagnf, Abdalhamid M., Frens, Jeremy J., Webb, Andrew J., Veve, Michael P., Stevens, Ryan, Bouchard, Jeannette, Gore, Tristan W., Ansari, Iman, Rybak, Michael J.
Publicado 2022

Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections

por Morrisette, Taylor, Alosaimy, Sara, Philley, Julie V, Wadle, Carly, Howard, Catessa, Webb, Andrew J, Veve, Michael P, Barger, Melissa L, Bouchard, Jeannette, Gore, Tristan W, Lagnf, Abdalhamid M, Ansari, Iman, Mejia-Chew, Carlos, Cohen, Keira A, Rybak, Michael J
Publicado 2021

Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes

por El Ghali, Amer, Morrisette, Taylor, Alosaimy, Sara, Lucas, Kristen, Tupayachi-Ortiz, Maria G., Vemula, Raaga, Wadle, Carly, Philley, Julie V., Mejia-Chew, Carlos, Hamad, Yasir, Stevens, Ryan W., Zeuli, John D., Webb, Andrew J., Fiske, Christina T., Simonyan, Anahit, Cimino, Christo L., Mammadova, Mehriban, Umana, Virginia E., Hasbun, Rodrigo, Butt, Saira, Molina, Kyle C., Thomas, Michael, Kaip, Emily A., Bouchard, Jeannette, Gore, Tristan W., Howard, Catessa, Cabanilla, M. Gabriela, Holger, Dana J., Frens, Jeremy J., Barger, Melissa, Ong, Aaron, Cohen, Keira A., Rybak, Michael J.
Publicado 2023